Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$13.17 - $16.4 $3,371 - $4,198
-256 Closed
0 $0
Q4 2020

Jan 12, 2021

SELL
$15.39 - $18.97 $4,570 - $5,634
-297 Reduced 53.71%
256 $5,000
Q4 2019

Jan 29, 2020

SELL
$16.88 - $20.83 $3,392 - $4,186
-201 Reduced 26.66%
553 $11,000
Q3 2019

Oct 03, 2019

BUY
$16.15 - $17.99 $12,177 - $13,564
754 New
754 $13,000
Q2 2019

Jul 15, 2019

SELL
$16.58 - $20.49 $13,661 - $16,883
-824 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$16.7 - $21.52 $13,760 - $17,732
824 New
824 $17,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.